A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART)

drug protocol number
EMR200061_506
drug sponsor
Merck Serono
drug study
Lutropin alfa
drug trial site
King Abdulaziz University Hospital (Jeddah)
drug status
Terminated
drug phase